Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Richard

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
Iscience|December 14, 2022
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBDYaozong Chen, Jérémie Prévost, Irfan Ullah, et al.
The Journal of Clinical Investigation|February 26, 2021
Identification of SARS-CoV-2-specific immune alterations in acutely ill patientsRose-Marie Rébillard, Marc Charabati, Camille Grasmuck, et al.
Science Advances|November 26, 2021
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortalityElsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner, et al.
Nature Communications|May 16, 2024
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunityElsa Brunet-Ratnasingham, Sacha Morin, Haley E Randolph, et al.
Journal of Chemical Theory and Computation|May 22, 2023
The OpenMolcas <i>Web</i>: A Community-Driven Approach to Advancing Computational ChemistryGiovanni Li Manni, Ignacio Fdez Galván, Ali Alavi, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
Iscience|December 14, 2022
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBDYaozong Chen, Jérémie Prévost, Irfan Ullah, et al.
The Journal of Clinical Investigation|February 26, 2021
Identification of SARS-CoV-2-specific immune alterations in acutely ill patientsRose-Marie Rébillard, Marc Charabati, Camille Grasmuck, et al.
Science Advances|November 26, 2021
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortalityElsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner, et al.
Nature Communications|May 16, 2024
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunityElsa Brunet-Ratnasingham, Sacha Morin, Haley E Randolph, et al.
Journal of Chemical Theory and Computation|May 22, 2023
The OpenMolcas <i>Web</i>: A Community-Driven Approach to Advancing Computational ChemistryGiovanni Li Manni, Ignacio Fdez Galván, Ali Alavi, et al.
Pageof 20